CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04802876
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:42.992094+00:00
Published At: 2025-03-21T00:00:00+00:00
Record Updated At: 2025-03-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["MSI-H Colorectal Cancer", "Melanoma", "Anal Carcinoma", "Mesothelioma", "Triple Negative Breast Cancer", "Lung Adenocarcinoma", "Cholangiocarcinoma", "Cervical Carcinoma", "Kidney Clear Cell Carcinoma", "Stomach Adenocarcinoma", "Esophageal Adenocarcinoma", "Uterine Adenocarcinoma", "Head and Neck Squamous Cell Carcinoma", "Sarcoma", "Lung Squamous Cell Carcinoma", "Urothelial Carcinoma", "Thyroid Carcinoma", "Hepatocellular Carcinoma", "Uveal Melanoma", "HER2-positive Breast Cancer", "Pancreatic Adenocarcinoma", "Squamous Esophageal Carcinoma", "Epithelial Ovarian Cancer", "Uterine Carcinosarcoma", "Small Cell Lung Cancer", "Hormone Receptor Positive / HER2-negative Breast Cancer", "Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation", "Colorectal Adenocarcinoma", "Prostate Adenocarcinoma", "Carcinoma of Unknown Primary", "Other Histology"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-03-21"
protocolSection.identificationModule.nctId: "NCT04802876"
protocolSection.identificationModule.officialTitle: "Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.